Wire · opportunities
KRTL Biotech Appoints Federal Controlled-Substance Compliance Specialist Justin Abril as ...
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 15 September 2026 · Fusion42 review
KRTL Biotech appointed Justin Abril, a federal controlled-substance compliance specialist with deep expertise in DEA regulatory affairs, Schedule I manufacturing, and pharmaceutical quality systems, as President-Designate and Strategic Regulatory & API Consultant to strengthen its regulatory and operational capabilities.
This Wire brief sits within Fusion42's coverage of Biotech.
◆ ◆ The Wire takeaway
You gain a dedicated expert on federal controlled-substance rules, which clears regulatory hurdles that could otherwise slow your pharmaceutical or botanical drug API projects. This hire unlocks DEA registration and compliance pathways you need to build and partner on Schedule I drug manufacturing.
◆ Coverage
1 source · 15 Sep 2026
◆ Related on Wire
◆ Topics